ALLEGRA MEDICAL TECHNOLOGIES LIMITED - Announcements

0.00%

2.9¢

Currently unlisted.

Allegra Medical Technologies Limited, formerly Allegra Orthopaedics Limited, is a... Allegra Medical Technologies Limited, formerly Allegra Orthopaedics Limited, is a biotechnology company. The Company is engaged in the medical device industry with its pioneering three dimensional (3D)-printed Sr-HT and Sr-HT-Gahnite orthopedic devices. It holds exclusive ownership of bio ceramic material, along with registered patents and patent applications from the University of Sydney. This material has several applications, including its use as a cervical fusion cage in spinal surgery, offering treatment options for patients. The Company is developing Sr-HT ceramic material to demonstrate the bioactivity required for bone regeneration. Sr-HT-Gahnite features bioactivity, biocompatibility, and mechanical properties suitable for load- bearing orthopedic implants. The primary focus centers on commercializing the Sr-HT Gahnite Bone substitute.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

AMT	Half Yearly Report and Accounts	PRICE SENSITIVE	22/02/13	1.14MB	Share
AMT	Placement and Rights Issue	PRICE SENSITIVE	18/02/13	165.3KB	Share
AMT	Preliminary Final Report	PRICE SENSITIVE	31/08/12	758.06KB	Share
AMT	Executive Management Changes	PRICE SENSITIVE	26/03/12	174.28KB	Share
AMT	Appendix 4D - Half Yearly Report	PRICE SENSITIVE	27/02/12	1.07MB	Share
AMT	ASDM Expands Product Portfolio	PRICE SENSITIVE	16/02/12	102.25KB	Share
AMT	ASDM enters the $250M Australian Spinal Market	PRICE SENSITIVE	20/09/11	179.11KB	Share
AMT	Preliminary Final Report	PRICE SENSITIVE	31/08/11	807.19KB	Share
AMT	Signs Commercial Arrangement with Surgeon Group	PRICE SENSITIVE	04/03/11	165.9KB	Share
AMT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/11	1.14MB	Share
AMT	ASDM Completes Strategic Review	PRICE SENSITIVE	16/02/11	171.83KB	Share
AMT	Positive Interim Results - PAD Clinical Trial	PRICE SENSITIVE	06/12/10	185.97KB	Share
AMT	International and Domestic Sales Growth	PRICE SENSITIVE	15/11/10	177.05KB	Share
AMT	New Distribution Agreement Broadens Market	PRICE SENSITIVE	04/11/10	219.8KB	Share
AMT	New Agreement for Substantial Growth in Sales and Profit	PRICE SENSITIVE	20/10/10	245.38KB	Share
AMT	Major New Revenue Opportunties	PRICE SENSITIVE	20/09/10	177.94KB	Share
AMT	Preliminary Final Report	PRICE SENSITIVE	31/08/10	630.02KB	Share
AMT	ASDM Signs Landmark PAD Licensing Deal	PRICE SENSITIVE	06/07/10	175.76KB	Share
AMT	First PAD Patient Discharged after Successful Treatment	PRICE SENSITIVE	04/06/10	172.14KB	Share
AMT	ASDM Establishes Direct Presence in Europe	PRICE SENSITIVE	19/05/10	23.96KB	Share
AMT	Major Trial for World-first Limb Saving Device Gets Go-ahead	PRICE SENSITIVE	09/04/10	44.55KB	Share
AMT	FDA Registration for Posterior Stabilised Knee	PRICE SENSITIVE	01/03/10	21.84KB	Share
AMT	Half Yearly Report and Accounts	PRICE SENSITIVE	22/02/10	1.06MB	Share
AMT	First Sales into Continental Europe	PRICE SENSITIVE	02/12/09	30.12KB	Share
AMT	Surgical device sold to US Multi-national	PRICE SENSITIVE	29/10/09	80.5KB	Share
AMT	Preliminary Final Report	PRICE SENSITIVE	26/08/09	2.43MB	Share
AMT	PAD Granted TGA Approval	PRICE SENSITIVE	10/08/09	31.87KB	Share
AMT	Appendix 4D - Results Announcement	PRICE SENSITIVE	25/02/09	24.46KB	Share

AMT Half Yearly Report and Accounts
22/02/13	PRICE SENSITIVE	1.14MB	Share
AMT Placement and Rights Issue
18/02/13	PRICE SENSITIVE	165.3KB	Share
AMT Preliminary Final Report
31/08/12	PRICE SENSITIVE	758.06KB	Share
AMT Executive Management Changes
26/03/12	PRICE SENSITIVE	174.28KB	Share
AMT Appendix 4D - Half Yearly Report
27/02/12	PRICE SENSITIVE	1.07MB	Share
AMT ASDM Expands Product Portfolio
16/02/12	PRICE SENSITIVE	102.25KB	Share
AMT ASDM enters the $250M Australian Spinal Market
20/09/11	PRICE SENSITIVE	179.11KB	Share
AMT Preliminary Final Report
31/08/11	PRICE SENSITIVE	807.19KB	Share
AMT Signs Commercial Arrangement with Surgeon Group
04/03/11	PRICE SENSITIVE	165.9KB	Share
AMT Half Yearly Report and Accounts
28/02/11	PRICE SENSITIVE	1.14MB	Share
AMT ASDM Completes Strategic Review
16/02/11	PRICE SENSITIVE	171.83KB	Share
AMT Positive Interim Results - PAD Clinical Trial
06/12/10	PRICE SENSITIVE	185.97KB	Share
AMT International and Domestic Sales Growth
15/11/10	PRICE SENSITIVE	177.05KB	Share
AMT New Distribution Agreement Broadens Market
04/11/10	PRICE SENSITIVE	219.8KB	Share
AMT New Agreement for Substantial Growth in Sales and Profit
20/10/10	PRICE SENSITIVE	245.38KB	Share
AMT Major New Revenue Opportunties
20/09/10	PRICE SENSITIVE	177.94KB	Share
AMT Preliminary Final Report
31/08/10	PRICE SENSITIVE	630.02KB	Share
AMT ASDM Signs Landmark PAD Licensing Deal
06/07/10	PRICE SENSITIVE	175.76KB	Share
AMT First PAD Patient Discharged after Successful Treatment
04/06/10	PRICE SENSITIVE	172.14KB	Share
AMT ASDM Establishes Direct Presence in Europe
19/05/10	PRICE SENSITIVE	23.96KB	Share
AMT Major Trial for World-first Limb Saving Device Gets Go-ahead
09/04/10	PRICE SENSITIVE	44.55KB	Share
AMT FDA Registration for Posterior Stabilised Knee
01/03/10	PRICE SENSITIVE	21.84KB	Share
AMT Half Yearly Report and Accounts
22/02/10	PRICE SENSITIVE	1.06MB	Share
AMT First Sales into Continental Europe
02/12/09	PRICE SENSITIVE	30.12KB	Share
AMT Surgical device sold to US Multi-national
29/10/09	PRICE SENSITIVE	80.5KB	Share
AMT Preliminary Final Report
26/08/09	PRICE SENSITIVE	2.43MB	Share
AMT PAD Granted TGA Approval
10/08/09	PRICE SENSITIVE	31.87KB	Share
AMT Appendix 4D - Results Announcement
25/02/09	PRICE SENSITIVE	24.46KB	Share

REFRESH

First

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

ALLEGRA MEDICAL TECHNOLOGIES LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available